Product
Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
1 clinical trial
1 indication
Indication
GoutClinical trial
A Phase Ib/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutStatus: Recruiting, Estimated PCD: 2023-09-01